Log In
Print
BCIQ
Print
Print this Print this
 

Edarbi, azilsartan medoxomil (TAK-491)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOral angiotensin II type 1 (AT1) receptor blocker (ARB)
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationHypertension
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today